HTG, Inc., a provider of novel array-based gene expression assay technology and services for the life sciences industry, today announced the availability of a new ArrayPlate to measure four genes in each well of a 384-well plate for high throughput screening and profiling. The ArrayPlate 384-4 enables researchers in the pharmaceutical and biotechnology industries to rapidly and accurately quantify RNA expression levels in cells treated with potential new drugs with high sample throughput, 10,000 or more samples per hour, and whole assay CV's of less than 10%.
